Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers. - Wikidata - awgldk - TriplyDB

Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers.

Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers.

http://www.wikidata.org/entity/Q33783620

about

Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer.

P2860

Q53799750-C60C6299-3109-480D-9686-5F1E0C4696FC

P2860

Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers.

http://www.wikidata.org/entity/Q33783620

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Diagnostic value and relative ...... significant prostate cancers.

@ast

Diagnostic value and relative ...... significant prostate cancers.

@en

type

label

Diagnostic value and relative ...... significant prostate cancers.

@ast

Diagnostic value and relative ...... significant prostate cancers.

@en

prefLabel

Diagnostic value and relative ...... significant prostate cancers.

@ast

Diagnostic value and relative ...... significant prostate cancers.

@en

P1433

Q33783620-A9ACC622-5CD7-4EE9-BB62-4B729792592C

P1476

Q33783620-C4C82B74-F6A7-42E6-B4DC-FE988FE8DEB1

P2093

Q33783620-0F770639-8319-4AA5-A016-D2CCA9144C02

Q33783620-12584F30-1A9A-45EB-A492-01247BA1A40E

Q33783620-2A95039F-38AB-4938-B0AC-FA170D16514C

Q33783620-3B0372A7-7FBB-418A-9998-5087982C96BD

Q33783620-56DFB696-4D92-4DA4-9576-EABC8F6FCA5B

Q33783620-716D157C-D4D4-4C28-9326-3FFCD9A89B89

Q33783620-9DE068AE-4608-422D-9A1F-88A53C1894BE

Q33783620-B2D02F92-AEDF-4188-838E-2B3539E8EFC5

Q33783620-D37EDBCF-5127-4B3C-B609-9D6F68D73224

P2860

Q33783620-013FB7EA-D30A-4CAF-8162-74F0AAF54CE0

Q33783620-08688248-CCF5-4D58-96CF-F6CA3FB9DFEB

Q33783620-0AA20DCE-0931-4E43-B33F-65651D961C04

Q33783620-1A0D86A1-2BB3-44E1-BF24-EC279654F7FE

Q33783620-1A5E819F-3864-4F37-8E25-0BE36160F9E2

Q33783620-1D823CF2-41C4-46AC-8769-AECC0EBF2292

Q33783620-1D926C81-872F-4180-AC61-56F2AA36BB76

Q33783620-2387C803-1DED-4335-B9B7-6F031F2CE282

Q33783620-2BF5BD0B-5BC6-4512-9E06-F8B9D21735C9

Q33783620-35069DC6-3E3A-4A7C-AE73-66825D7AF238

P304

Q33783620-F6EBD845-801A-43DC-834B-74E5F716B3EA

P31

Q33783620-F4FD74E1-E3D1-45A2-9C2E-02E908AFD01F

P356

Q33783620-2D300F56-57E3-4876-997C-B31F97042E8C

P407

Q33783620-9A19D188-BB4E-4B45-814C-0B338CC3E1C9

P433

Q33783620-78184694-7BCA-4EE1-8757-90CF95F3C399

P478

Q33783620-F1E2FB6E-EDCC-4D5D-A1D9-77B1D7AEB2EC

P50

Q33783620-05C8A6A1-7228-47C2-94D9-26F3A6AADECF

P577

Q33783620-4BF51D36-8D22-4AEA-9AD0-39E2B9D60572

P698

Q33783620-44F05AF2-5EA2-4B47-99E5-0EA3D0AEDCCE

P932

Q33783620-6A9CF8D6-0D63-4D22-9604-844F8B77BD56

P356

JOURNAL.PONE.0178901

P1433

P1476

Diagnostic value and relative ...... significant prostate cancers.

@en

P2093

Alain Ruffion

http://www.w3.org/2001/XMLSchema#string

Fanny Cros

http://www.w3.org/2001/XMLSchema#string

Flavie Bratan

http://www.w3.org/2001/XMLSchema#string

Florence Mège-Lechevallier

http://www.w3.org/2001/XMLSchema#string

Laurent Roche

http://www.w3.org/2001/XMLSchema#string

Marc Colombel

http://www.w3.org/2001/XMLSchema#string

Muriel Rabilloud

http://www.w3.org/2001/XMLSchema#string

Sébastien Crouzet

http://www.w3.org/2001/XMLSchema#string

Tristan Dagonneau

http://www.w3.org/2001/XMLSchema#string

P2860

ESUR prostate MR guidelines 2012

PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2

Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales.

Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis.

Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy.

Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy.

Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference

Prostate Imaging Reporting and Data System (PI-RADS), Version 2: A Critical Look.

Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.

Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation

P304

e0178901

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0178901

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Rouviere

P577

2017-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28599001

http://www.w3.org/2001/XMLSchema#string

P932

5466299

http://www.w3.org/2001/XMLSchema#string